![](/img/cover-not-exists.png)
Treatment of low-risk myelodysplastic syndromes with high-dose daily oral cholecalciferol (2000–4000 IU vitamin D3)
Molnár, I, Stark, N, Lovato, J, Powell, B L, Cruz, J, Hurd, D D, Mathieu, J S, Chen, T C, Holick, M F, Cambra, S, McQuellon, R P, Schwartz, G GLanguage:
english
Pages:
4
Journal:
Leukemia
DOI:
10.1038/sj.leu.2404601
Date:
March, 2007
File:
PDF, 109 KB
english, 2007